Steroid use in GBM correlates with poor outcome
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Patients receiving Dex have reduced rates of survival 1 .
Several studies have questioned safe use of Gc as part of standard therapy, i.e. alongside radiotherapy and chemotherapy
Effect of steroids on cancer cell survival
M059K cells were irradiated (IR) or treated with chemotherapy, temozolomide (TMZ) following Gc or vehicle treatment. Cell survival was analysed by MTT assay (n=3).
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Gc increase survival of GBM cells following IR and TMZ Gc-regulated genes (red) identified by the RNA-seq were combined with our previously published list of GR binding proteins (green) to identify potential candidates linking Gc action to DNA repair pathways.
Future Work
Gc may affect DNA repair through multiple mechanisms 50nM and 500nM Hydrocortisone (HC) mimics the physiological evening and morning levels of circulating cortisol respectively.
100nM Dexamethasone (Dex) mimics the dosage of synthetic Gc given as therapy in GBM.
The study aims to investigate the GBM cell response to both the endogenous Gc, cortisol, and the synthetic Gc, Dex, which forms part of therapy. 
Gc regulate genes which may contribute to therapeutic resistance
Gene ontology analysis of the Gc regulated genes using Enrichr identifies key pathways under Gc control in GBM, relevant to inflammation (green) and cancer (red).
GBM (M059K) cells were treated for 4 hours with vehicle, low HC, high HC or Dex and analysed by RNA-seq.
In total, we identify 266 genes that are regulated by Gc in GBM cells.
• 37 genes were regulated by all 3 treatments • 72 genes were only regulated in response to peak HC and Dex.
• 140 genes were regulated in response to Dex alone. 
Genome wide transcriptional response to steroids in GBM
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